GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Long-Term Debt

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Long-Term Debt : ¥4,037 Mil (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zhejiang Huahai Pharmaceutical Co Long-Term Debt?

Zhejiang Huahai Pharmaceutical Co's Long-Term Debt for the quarter that ended in Sep. 2024 was ¥4,037 Mil.

Zhejiang Huahai Pharmaceutical Co's quarterly Long-Term Debt declined from Mar. 2024 (¥4,002 Mil) to Jun. 2024 (¥3,943 Mil) but then increased from Jun. 2024 (¥3,943 Mil) to Sep. 2024 (¥4,037 Mil).

Zhejiang Huahai Pharmaceutical Co's annual Long-Term Debt increased from Dec. 2021 (¥3,498 Mil) to Dec. 2022 (¥4,635 Mil) but then declined from Dec. 2022 (¥4,635 Mil) to Dec. 2023 (¥4,022 Mil).


Zhejiang Huahai Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Zhejiang Huahai Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huahai Pharmaceutical Co Long-Term Debt Chart

Zhejiang Huahai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,179.19 2,921.07 3,497.87 4,635.34 4,022.21

Zhejiang Huahai Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,582.80 4,022.21 4,001.60 3,942.72 4,037.28

Zhejiang Huahai Pharmaceutical Co  (SHSE:600521) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Zhejiang Huahai Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Zhejiang Huahai Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Huahai Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Xunqiao, Zhejiang Province, Linhai, Linhai, CHN, 317024
Zhejiang Huahai Pharmaceutical Co Ltd is engaged in Research & Development, production and sales of multi-dosage preparations, biological drugs, innovative drugs and specialty APIs.
Executives
Lin Li Hong senior management
Xu Mi senior management
Gang Hui senior management
He Bin senior management
Kong Xiao Fang senior management
Chen Bao Hua Director
Shang Fei senior management
Du Jun Director
Su Yan Director
Chen Dun Yuan senior management
Li Hong Director
Guo Si Jia senior management
Li Min senior management
Xu Bo senior management
Chen Qi Mao senior management

Zhejiang Huahai Pharmaceutical Co Headlines

No Headlines